Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Current Assets (2016 - 2025)

Historic Current Assets for Lexaria Bioscience (LEXX) over the last 15 years, with Q4 2025 value amounting to $5.4 million.

  • Lexaria Bioscience's Current Assets fell 3923.31% to $5.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was $5.4 million, marking a year-over-year decrease of 3923.31%. This contributed to the annual value of $3.5 million for FY2025, which is 5608.57% down from last year.
  • Lexaria Bioscience's Current Assets amounted to $5.4 million in Q4 2025, which was down 3923.31% from $3.5 million recorded in Q3 2025.
  • Lexaria Bioscience's 5-year Current Assets high stood at $12.4 million for Q3 2021, and its period low was $2.2 million during Q3 2023.
  • For the 5-year period, Lexaria Bioscience's Current Assets averaged around $7.1 million, with its median value being $7.4 million (2022).
  • As far as peak fluctuations go, Lexaria Bioscience's Current Assets soared by 82762.46% in 2021, and later plummeted by 6916.94% in 2023.
  • Over the past 5 years, Lexaria Bioscience's Current Assets (Quarter) stood at $10.9 million in 2021, then plummeted by 50.84% to $5.4 million in 2022, then tumbled by 49.74% to $2.7 million in 2023, then skyrocketed by 227.65% to $8.8 million in 2024, then plummeted by 39.23% to $5.4 million in 2025.
  • Its Current Assets stands at $5.4 million for Q4 2025, versus $3.5 million for Q3 2025 and $5.8 million for Q2 2025.